140 related articles for article (PubMed ID: 18081149)
1. A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines.
Sirica AE; Zhang Z; Lai GH; Asano T; Shen XN; Ward DJ; Mahatme A; Dewitt JL
Hepatology; 2008 Apr; 47(4):1178-90. PubMed ID: 18081149
[TBL] [Abstract][Full Text] [Related]
2. Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas.
Dumur CI; Campbell DJ; DeWitt JL; Oyesanya RA; Sirica AE
Exp Mol Pathol; 2010 Dec; 89(3):227-35. PubMed ID: 20816680
[TBL] [Abstract][Full Text] [Related]
3. erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer.
Lai GH; Zhang Z; Shen XN; Ward DJ; Dewitt JL; Holt SE; Rozich RA; Hixson DC; Sirica AE
Gastroenterology; 2005 Dec; 129(6):2047-57. PubMed ID: 16344070
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma.
Radaeva S; Ferreira-Gonzalez A; Sirica AE
Hepatology; 1999 May; 29(5):1453-62. PubMed ID: 10216129
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/Neu.
Rozich RA; Mills DR; Brilliant KE; Callanan HM; Yang D; Tantravahi U; Hixson DC
Exp Mol Pathol; 2010 Dec; 89(3):248-59. PubMed ID: 20655306
[TBL] [Abstract][Full Text] [Related]
6. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.
Okabe H; Beppu T; Ueda M; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Mima K; Miyake K; Iwatsuki M; Baba Y; Takamori H; Jono H; Shinriki S; Ando Y; Baba H
Int J Cancer; 2012 Nov; 131(10):2234-41. PubMed ID: 22337081
[TBL] [Abstract][Full Text] [Related]
7. TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro.
Reich M; Deutschmann K; Sommerfeld A; Klindt C; Kluge S; Kubitz R; Ullmer C; Knoefel WT; Herebian D; Mayatepek E; Häussinger D; Keitel V
Gut; 2016 Mar; 65(3):487-501. PubMed ID: 26420419
[TBL] [Abstract][Full Text] [Related]
8. NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.
Sirica AE; Radaeva S; Caran N
Am J Pathol; 1997 Dec; 151(6):1685-94. PubMed ID: 9403719
[TBL] [Abstract][Full Text] [Related]
9. Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development.
Lozano E; Sanchez-Vicente L; Monte MJ; Herraez E; Briz O; Banales JM; Marin JJ; Macias RI
Mol Cancer Res; 2014 Jan; 12(1):91-100. PubMed ID: 24255171
[TBL] [Abstract][Full Text] [Related]
10. Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.
Noda T; Shimoda M; Ortiz V; Sirica AE; Wands JR
Hepatology; 2012 Jan; 55(1):86-97. PubMed ID: 21898484
[TBL] [Abstract][Full Text] [Related]
11. Leptin enhances cholangiocarcinoma cell growth.
Fava G; Alpini G; Rychlicki C; Saccomanno S; DeMorrow S; Trozzi L; Candelaresi C; Venter J; Di Sario A; Marzioni M; Bearzi I; Glaser S; Alvaro D; Marucci L; Francis H; Svegliati-Baroni G; Benedetti A
Cancer Res; 2008 Aug; 68(16):6752-61. PubMed ID: 18701500
[TBL] [Abstract][Full Text] [Related]
12. Akt expression may predict favorable prognosis in cholangiocarcinoma.
Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2.
Yoon H; Min JK; Lee JW; Kim DG; Hong HJ
Biochem Biophys Res Commun; 2011 Feb; 405(3):333-7. PubMed ID: 21130731
[TBL] [Abstract][Full Text] [Related]
14. Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver.
Lai GH; Radaeva S; Nakamura T; Sirica AE
Hepatology; 2000 Jun; 31(6):1257-65. PubMed ID: 10827151
[TBL] [Abstract][Full Text] [Related]
15. Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line.
Tadlock L; Patel T
Hepatology; 2001 Jan; 33(1):43-51. PubMed ID: 11124819
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
Choi HJ; Kim HJ; Choi JH
Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
Zhang Z; Lai GH; Sirica AE
Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907
[TBL] [Abstract][Full Text] [Related]
18. Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma.
Tanaka S; Sugimachi K; Kameyama T; Maehara S; Shirabe K; Shimada M; Wands JR; Maehara Y
Hepatology; 2003 May; 37(5):1122-9. PubMed ID: 12717393
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.
Meng F; Yamagiwa Y; Ueno Y; Patel T
J Hepatol; 2006 Jun; 44(6):1055-65. PubMed ID: 16469407
[TBL] [Abstract][Full Text] [Related]
20. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
